Woldu S - Search Results

1

Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.

Freifeld Y, Ghandour R, Singla N, Woldu S, Clinton T, Kulangara R, Bagrodia A, Matin SF, Petros FG, Raman JD, Robyak H, Yan J, Zhu H, Rapoport L, Lotan Y, Margulis V. Freifeld Y, et al. Among authors: woldu s. Urol Oncol. 2019 Oct;37(10):758-764. doi: 10.1016/j.urolonc.2019.06.009. Epub 2019 Aug 2. Urol Oncol. 2019. PMID: 31378586

2

Utilization of the Robotic Surgical Platform for Radical Nephrectomy: A National Comparison of Trends for Open, Laparoscopic and Robotic Approaches.

Weinberg AC, Whalen MJ, Paulucci DJ, Woldu S, Deibert CM, Korets R, Badani KK. Weinberg AC, et al. Among authors: woldu s. Urol Pract. 2016 May;3(3):187-194. doi: 10.1016/j.urpr.2015.07.007. Epub 2016 Feb 22. Urol Pract. 2016. PMID: 37592502

3

Who really benefits from nephron-sparing surgery?

Woldu SL, Weinberg AC, Korets R, Ghandour R, Danzig MR, RoyChoudhury A, Kalloo SD, Benson MC, DeCastro GJ, McKiernan JM. Woldu SL, et al. Urology. 2014 Oct;84(4):860-7. doi: 10.1016/j.urology.2014.05.061. Urology. 2014. PMID: 25260447

4

Comparison of Renal Parenchymal Volume Preservation Between Partial Nephrectomy, Cryoablation, and Radiofrequency Ablation Using 3D Volume Measurements.

Woldu SL, Thoreson GR, Okhunov Z, Ghandour R, Rothberg MB, RoyChoudhury A, Kim HH, Bozoghlanian M, Newhouse JH, Helmy MA, Badani KK, Landman J, Cadeddu JA, McKiernan JM. Woldu SL, et al. J Endourol. 2015 Aug;29(8):948-55. doi: 10.1089/end.2014.0866. Epub 2015 Mar 19. J Endourol. 2015. PMID: 25578645

5

Close surgical margins after radical prostatectomy mimic biochemical recurrence rates of positive margins.

Whalen MJ, Shapiro EY, Rothberg MB, Turk AT, Woldu SL, Roy Choudhury A, Patel T, Badani KK. Whalen MJ, et al. Urol Oncol. 2015 Nov;33(11):494.e9-494.e14. doi: 10.1016/j.urolonc.2015.07.005. Epub 2015 Aug 8. Urol Oncol. 2015. PMID: 26259665

6

Re: Efficacy of High-intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis from the National Cancer Data Base.

Woldu SL, Lotan Y. Woldu SL, et al. Eur Urol. 2016 Nov;70(5):893. doi: 10.1016/j.eururo.2016.07.040. Epub 2016 Aug 4. Eur Urol. 2016. PMID: 27498598 No abstract available.

7

Testicular germ cell tumor genomics.

Woldu SL, Amatruda JF, Bagrodia A. Woldu SL, et al. Curr Opin Urol. 2017 Jan;27(1):41-47. doi: 10.1097/MOU.0000000000000347. Curr Opin Urol. 2017. PMID: 27584029 Free PMC article. Review.

8

Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence.

Krabbe LM, Woldu SL, Shariat SF, Lotan Y. Krabbe LM, et al. Expert Rev Mol Diagn. 2016 Nov;16(11):1189-1199. doi: 10.1080/14737159.2016.1244006. Epub 2016 Oct 14. Expert Rev Mol Diagn. 2016. PMID: 27696932 Review.

9

Single nucleotide polymorphisms of the vascular endothelial growth factor receptor - a promising biomarker in metastatic renal cell carcinoma.

Woldu SL, Margulis V. Woldu SL, et al. BJU Int. 2016 Dec;118(6):847-848. doi: 10.1111/bju.13617. BJU Int. 2016. PMID: 27870360 No abstract available.

10

Guideline of guidelines: non-muscle-invasive bladder cancer.

Woldu SL, Bagrodia A, Lotan Y. Woldu SL, et al. BJU Int. 2017 Mar;119(3):371-380. doi: 10.1111/bju.13760. Epub 2017 Jan 24. BJU Int. 2017. PMID: 28058776 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page